Open AccessIs it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe?
Author(s) -
Rao Vijaya L.,
Daugherty Christopher
Publication year - 2015
Publication title -
clinical liver disease
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.421
H-Index - 14
ISSN - 2046-2484
DOI - 10.1002/cld.512
Subject(s) - medicine , adverse effect , clinical trial , ribavirin , regimen , intensive care medicine , hepatitis c , hepatitis c virus , randomized controlled trial , immunology , virus
Watch a video presentation of this article Watch the interview with the author
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom